Related Experiment Video
Updated: Jun 10, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Katrin Düvel1, Jessica L Yecies, Suchithra Menon
1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Abstract:
Aberrant activation of the mammalian target of rapamycin complex 1 (mTORC1) is a common molecular event in a variety of pathological settings, including genetic tumor syndromes, cancer, and obesity. However, the cell-intrinsic consequences of mTORC1 activation remain poorly defined. Through a combination of unbiased genomic, metabolomic, and bioinformatic approaches, we demonstrate that mTORC1 activation is sufficient to stimulate specific metabolic pathways, including glycolysis, the oxidative arm of the pentose phosphate pathway, and de novo lipid biosynthesis. This is achieved through the activation of a transcriptional program affecting metabolic gene targets of hypoxia-inducible factor (HIF1alpha) and sterol regulatory element-binding protein (SREBP1 and SREBP2). We find that SREBP1 and 2 promote proliferation downstream of mTORC1, and the activation of these transcription factors is mediated by S6K1. Therefore, in addition to promoting protein synthesis, mTORC1 activates specific bioenergetic and anabolic cellular processes that are likely to contribute to human physiology and disease.
Insights
Aberrant activation of the mammalian target of rapamycin complex 1 (mTORC1) stimulates key metabolic pathways like glycolysis and lipid synthesis. This mTORC1 activation drives cell proliferation and contributes to various diseases.
Area of Science:
- Cellular metabolism
- Molecular biology
- Cancer research
Background:
- Aberrant activation of the mammalian target of rapamycin complex 1 (mTORC1) is prevalent in pathological conditions such as cancer and obesity.
- The precise intracellular effects of mTORC1 activation are not fully understood.
Purpose of the Study:
- To elucidate the cell-intrinsic consequences of mTORC1 activation.
- To identify the metabolic pathways and transcriptional programs regulated by mTORC1.
Main Methods:
- Unbiased genomic, metabolomic, and bioinformatic analyses were employed.
- Investigated the role of hypoxia-inducible factor (HIF1alpha) and sterol regulatory element-binding proteins (SREBP1 and SREBP2) in mediating mTORC1 effects.
- Assessed the contribution of S6 kinase 1 (S6K1) in SREBP activation.
Main Results:
- mTORC1 activation was found to be sufficient for stimulating glycolysis, the pentose phosphate pathway, and de novo lipid biosynthesis.
- A transcriptional program involving HIF1alpha and SREBP1/2 targets was activated by mTORC1.
- SREBP1 and SREBP2 were identified as promoters of cell proliferation downstream of mTORC1, with S6K1 mediating their activation.
Conclusions:
- mTORC1 activation orchestrates specific metabolic and anabolic processes beyond protein synthesis.
- These mTORC1-driven pathways, including those regulated by SREBP transcription factors, play a significant role in cell proliferation and are implicated in human diseases.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Regulation of Metabolism
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

